Home › Prostate Cancer › Tennessee › Memphis
Prostate Cancer clinical trials in Memphis, TN
8 studies for Prostate Cancer are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
RecruitingPhase 2
- The Conrad Pearson Clinic, Germantown · 14 mi away
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- Memphis VA Medical Center ( Site 0072), Memphis
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecruitingPhase 3
- The West Clinic, PLLC dba West Cancer Center ( Site 0063), Germantown · 14 mi away
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi away
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RecruitingPhase 2
- Memphis VA Medical Center, Memphis, TN, Memphis
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecruitingObservational study
- Memphis VA Medical Center, Memphis
- Baptist Clinical Research Institute, Memphis
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- The West Clinic - Wolf River, Germantown · 14 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Memphis
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Memphis
- Cancer (all types)30 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer21 studies
- Sickle Cell Disease19 studies
- Acute Lymphoblastic Leukemia17 studies
- Lung Cancer17 studies
- Acute Myeloid Leukemia14 studies
- Heart Failure12 studies
- Melanoma11 studies
- Soft Tissue Sarcoma10 studies
- Colorectal Cancer10 studies
- Type 2 Diabetes10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.